Cullinan Oncology, Inc.
NASDAQ:CGEM
6.84 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.943 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.077 | 0.076 | 0.077 | 0.076 | 0.077 | 0.076 | 0.077 | 0.08 | 0.081 | 0.072 | 0.059 | 0.009 | 0 | 0 | 0.012 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.077 | -0.076 | -0.077 | -0.076 | -0.077 | -0.076 | -0.077 | -0.08 | -0.081 | -0.072 | -0.059 | -0.009 | 0 | 0 | -37.86 | -0.013 | -0.013 | 18.943 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 61.03 | 41.459 | 40.492 | 35.506 | 36.259 | 30.646 | 34.848 | 33.821 | 27.391 | 52.096 | 21.321 | 19.68 | 26.411 | 24.536 | 20.878 | 12.68 | 11.778 | 12.415 | 16.629 | 9.913 | 12.496 | 4.173 | 3.802 | 5.276 | 3.855 | 3.855 |
| General & Administrative Expenses
| 14.768 | 13.537 | 14.556 | 13.349 | 13.768 | 12.343 | 10.637 | 10.982 | 10.214 | 10.66 | 11.287 | 10.086 | 10.695 | 8.121 | 12.869 | 5.695 | 4.826 | 5.156 | 11.944 | 1.586 | 1.626 | 1.368 | 1.177 | 1.477 | 1.214 | 1.214 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | -0.077 | -0.076 | -0.077 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0 | 0 | 0 | 0.6 | 0 | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 |
| SG&A
| 14.768 | 13.537 | 14.556 | 13.349 | 13.691 | 12.267 | 10.56 | 10.982 | 10.214 | 10.66 | 11.287 | 10.086 | 10.695 | 8.121 | 13.469 | 5.695 | 4.826 | 5.156 | 12.544 | 1.586 | 1.626 | 1.368 | 1.177 | 1.677 | 1.314 | 1.314 |
| Other Expenses
| 0 | 0 | -0.077 | 0 | 0 | 0 | 0 | 0.44 | 0.069 | 0.107 | 0.298 | 0 | -0.241 | 0 | 0.004 | -0.002 | -0.008 | -0.002 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 75.798 | 54.996 | 54.971 | 48.855 | 49.95 | 42.913 | 45.408 | 45.243 | 37.605 | 62.756 | 32.608 | 29.766 | 37.106 | 32.657 | 34.346 | 18.375 | 16.604 | 17.571 | 29.173 | 11.499 | 14.122 | 5.541 | 4.979 | 6.95 | 5.171 | 5.171 |
| Operating Income
| -75.798 | -54.996 | -55.048 | -48.855 | -50.027 | -42.989 | -45.485 | -45.243 | -37.605 | -62.756 | -32.608 | -29.766 | 239.679 | -32.657 | -34.347 | -18.375 | -16.604 | 1.372 | -29.173 | -11.499 | -14.122 | -5.541 | -4.979 | -6.953 | -5.169 | -5.169 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 5.743 | 6.495 | 7.518 | 8.295 | 7.999 | 5.649 | 5.8 | 6.06 | 5.391 | 4.615 | 3.662 | 2.353 | 0.456 | 0.197 | 0.141 | 0.116 | 0.165 | 0.047 | 0.067 | 0.185 | 0.247 | 0.378 | 0.248 | 0.104 | 0.132 | 0.132 |
| Income Before Tax
| -70.055 | -48.501 | -47.53 | -40.56 | -42.028 | -37.34 | -39.685 | -39.183 | -32.214 | -58.141 | -28.946 | -27.413 | 240.135 | -32.46 | -34.206 | -18.259 | -16.439 | 1.419 | -29.106 | -11.314 | -13.875 | -5.163 | -4.731 | -6.849 | -5.037 | -5.037 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.075 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.117 | 0 | 0 | -0.192 | -14.122 | 0 | 0 | -0.179 | -1.858 | -2.523 | 66.07 | -19.568 | 0.223 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -70.055 | -48.501 | -47.647 | -40.56 | -42.028 | -37.148 | -23.803 | -39.183 | -32.214 | -57.962 | -26.782 | -24.804 | 174.898 | -12.098 | -32.514 | -17.35 | -15.636 | -0.07 | -28.346 | -9.858 | -8.622 | -4.973 | -4.569 | -6.583 | -4.752 | -4.752 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.19 | -0.82 | -0.81 | -0.7 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.9 | -0.27 | -0.74 | -0.4 | -0.36 | -0.002 | -0.68 | -0.26 | -0.45 | -0.26 | -0.24 | -6.83 | -5.94 | -5.94 |
| EPS Diluted
| -1.19 | -0.82 | -0.81 | -0.7 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.77 | -0.27 | -0.74 | -0.4 | -0.36 | -0.002 | -0.68 | -0.26 | -0.45 | -0.26 | -0.24 | -6.82 | -5.94 | -5.94 |
| EBITDA
| -75.798 | -54.92 | -54.971 | -48.779 | -49.95 | -42.913 | -45.408 | -44.723 | -37.524 | -62.684 | -32.549 | -29.757 | -35.394 | -32.644 | -34.335 | -18.362 | -16.591 | 1.387 | -29.158 | -11.484 | -13.859 | -5.525 | -4.962 | -6.937 | -5.15 | -5.15 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.073 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |